PubMed

The prince and the pauper. A tale of anticancer targeted agents.

Dueñas-González A, García-López P, Herrera LA, Medina-Franco JL, González-Fierro A, Candelaria M.

Mol Cancer. 2008 Oct 23;7:82. Review.PMID: 18947424 [PubMed - indexed for MEDLINE]Related articlesFree article

Anticancer Drug Development: The Way Forward.

Connors T.

Oncologist. 1996;1(3):180-181.PMID: 10387985 [PubMed - as supplied by publisher]Related articlesFree article

[Future directions of anticancer drug development in Japan]

Akaza H, Kawai K, Tsuruo T, Tsukagoshi S, Aiba K, Shimada Y, Kakeji Y, Ishikawa H, Ikeda T, Nakamura S, Tamura T, Yamamoto N, Isonishi S, Hinotsu S, Hirose M, Katsura J.

Gan To Kagaku Ryoho. 2008 Feb;35(2):351-60. Japanese. PMID: 18281781 [PubMed - indexed for MEDLINE]Related articles

The value of drug repositioning in the current pharmaceutical market.

Tobinick EL.

Drug News Perspect. 2009 Mar;22(2):119-25. Review.PMID: 19330170 [PubMed - indexed for MEDLINE]Related articles

Alternative strategies in drug development: clinical pharmacological aspects.

Kuhlmann J.

Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Review.PMID: 10599949 [PubMed - indexed for MEDLINE]Related articles

New paradigms for cancer drug discovery.

Sager JA, Lengauer C.

Cancer Biol Ther. 2003 Jul-Aug;2(4):452-5. Review.PMID: 14508120 [PubMed - indexed for MEDLINE]Related articlesFree article

New paradigms for cancer drug discovery.

Sager JA, Lengauer C.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S178-81. Review.PMID: 14508097 [PubMed - indexed for MEDLINE]Related articlesFree article

A new science-business paradigm in anticancer drug development.

Blagosklonny MV.

Trends Biotechnol. 2003 Mar;21(3):103-6.PMID: 12628364 [PubMed - indexed for MEDLINE]Related articles

Should financial incentives be used to differentially reward 'me-too' and innovative drugs?

Pekarsky B.

Pharmacoeconomics. 2010;28(1):1-17. doi: 10.2165/11318770-000000000-00000. Review.PMID: 20014872 [PubMed - indexed for MEDLINE]Related articles

Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention.

Grabowski HG, Moe JL.

Cancer Prev Res (Phila Pa). 2008 Jul;1(2):84-90. Epub 2008 Apr 14.PMID: 19138940 [PubMed - indexed for MEDLINE]Related articles

The value of improving the productivity of the drug development process: faster times and better decisions.

DiMasi JA.

Pharmacoeconomics. 2002;20 Suppl 3:1-10.PMID: 12457421 [PubMed - indexed for MEDLINE]Related articles

Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agents.

Vassal G, Méry-Mignard D, Caulin C.

Therapie. 2003 May-Jun;58(3):229-46. English, French. PMID: 14655318 [PubMed - indexed for MEDLINE]Related articles

[Biomarkers: "Found in translation"]

Lockhart BP, Walther B.

Med Sci (Paris). 2009 Apr;25(4):423-30. Review. French. PMID: 19409197 [PubMed - indexed for MEDLINE]Related articles

Trends in risks associated with new drug development: success rates for investigational drugs.

DiMasi JA, Feldman L, Seckler A, Wilson A.

Clin Pharmacol Ther. 2010 Mar;87(3):272-7. Epub 2010 Feb 3. Review.PMID: 20130567 [PubMed - indexed for MEDLINE]Related articles

Drug discovery and development in the pharmaceutical industry.

Schacter LP, Anderson C, Canetta RM, Kelley S, Nicaise C, Onetto N, Rozencweig M, Smaldone L, Winograd B.

Semin Oncol. 1992 Dec;19(6):613-21. Review.PMID: 1462163 [PubMed - indexed for MEDLINE]Related articles

[Front-line drug discovery system for cancer]

Mizukami T.

Gan To Kagaku Ryoho. 2008 Dec;35(13):2293-300. Review. Japanese. PMID: 19098393 [PubMed - indexed for MEDLINE]Related articles

Requirements for a lead compound to become a clinical candidate.

Hefti FF.

BMC Neurosci. 2008 Dec 10;9 Suppl 3:S7. Review.PMID: 19091004 [PubMed - indexed for MEDLINE]Related articlesFree article

Novel trends in high-throughput screening.

Mayr LM, Bojanic D.

Curr Opin Pharmacol. 2009 Oct;9(5):580-8. Epub 2009 Sep 21. Review.PMID: 19775937 [PubMed - indexed for MEDLINE]Related articles

The role of emerging genomics and proteomics technologies in cancer drug target discovery.

Onyango P.

Curr Cancer Drug Targets. 2004 Mar;4(2):111-24. Review.PMID: 15032664 [PubMed - indexed for MEDLINE]Related articles

The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

Rowinsky EK.

Drugs. 2000;60 Suppl 1:1-14; discussion 41-2. Review.PMID: 11129167 [PubMed - indexed for MEDLINE]Related articles